Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
Condition(s):Type 2 Diabetes; Coronary Artery Disease; Left Ventricular MassLast Updated:August 21, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes; Coronary Artery Disease; Left Ventricular MassLast Updated:August 21, 2015Completed
Condition(s):Growth Hormone Disorder; Adult Growth Hormone DeficiencyLast Updated:February 28, 2024Completed
Condition(s):FibroblastLast Updated:July 14, 2010Unknown status
Condition(s):Acromegaly; Heart Failure; Hypertrophy, Left VentricularLast Updated:September 24, 2010Unknown status
Condition(s):Renal Transplant Donor of Left Kidney; Renal Transplant Donor of Right KidneyLast Updated:February 24, 2021Completed
Condition(s):HypertensionLast Updated:September 17, 2014Terminated
Condition(s):Heart FailureLast Updated:April 9, 2010Completed
Condition(s):Ischemia Coronary Artery OriginLast Updated:October 25, 2018Completed
Condition(s):Peritoneal DialysisLast Updated:December 11, 2013Unknown status
Condition(s):Hypertrophy, Left VentricularLast Updated:September 29, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.